RankingsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Operating income

KYORIN Pharmaceutical Co., Ltd.【JP:4569】

Market cap
¥103.3B
P/E ratio
19.1x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Mar 31, 202512,567+109.00%
Mar 31, 20246,013+17.37%
Mar 31, 20235,123+2.32%
Mar 31, 20225,007-13.46%
Mar 31, 20215,786-22.88%
Mar 31, 20207,503-16.37%
Mar 31, 20198,972+1.70%
Mar 31, 20188,822-15.28%
Mar 31, 201710,413-46.97%
Mar 31, 201619,636+33.24%
Mar 31, 201514,737

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)